Solventum Corporation (NYSE:SOLV) is an independent entity now after the completion of its spin-off from 3M. As it began trading post spin-off, several notable investments have been seen including a $732k investment from Choreo LLC and a significant stake taken by Prudential Plc. Additionally, numerous assets under management, from Acadian Asset Management, CIBC Asset Management, among others, have acquired SOLV shares. SOLV has launched a new wound dressing tailor-made for V.A.CĀ® Therapy and has featured autonomous coding in Epic Toolbox. The company's Q1 and Q2 2024 earnings have beaten estimates, leading to an upwards revision to their full year guidance. Although SOLV stock has gained increased interest from analysts post-spin off, it has received a 'Reduce' recommendation from brokerages. Activist investors like Trian Fund Management and Nelson Peltz see value in SOLV and are encouraging the firm to unlock shareholder value.
Solventum Corporation SOLV News Analytics from Tue, 26 Oct 2021 13:29:18 GMT to Sun, 15 Sep 2024 13:44:45 GMT -
Rating 5
- Innovation 1
- Information 8
- Rumor -6
